Torrent has tempered US growth expectations while it plans to put its Dahej, Indrad and Levittown plants up for FDA inspection in 2020. Meanwhile, products launched in India, including remoglifozin in-licensed from Glenmark, have shown an encouraging uptake.

Torrent has tempered FY21 US growth expectations while it plans to put Dahej, Indrad and Levittown plants up for FDA inspection in 2020. Meanwhile, products launched in India, including remoglifozin in-licensed from Glenmark, have shown an encouraging uptake.

Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini –  among the key products at the core of the Indian firm’s OTC business.

Sun Pharma has blocked a group of firms attempting to ride on the trademark of its popular pain relief brand Volini –  among the key products at the core of the Indian firm’s OTC business.